Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd Interstitial Lung Disease Drug Development Summit

Evvnt Promotion / evvnt
-
07.03.2022 - 09.03.2022  Online, USA
Time: 9:00 AM - 5:05 PM
 
Temi della conferenza
With SSc-ILD on the cusp of regulatory approval following closely behind Pirfenidone’s breakthrough therapy designation to treat uILD earlier this year, and investment pouring across multiple ILD phenotypes, the window of therapeutic opportunity to develop clinically defining drugs to treat interstitial lung disease is well and truly open.
Professional congress organizer (PCO)
Hanson Wade
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/921955-2?pid=4832
Ms. Aarti Diwan
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 1699.00 - USD 3497.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Anästhesie in Entwicklungsländern e. V.newTreeAlumni Club Medizinische Universität WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Helix - Forschung & Beratung WienHilfswerk AustriaSwiss Tropical and Public Health InstituteEuropean Public Health Association (EUPHA)